Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NYC Surgical Associates is a private New York-based multi-specialty surgical and interventional practice focused on minimally invasive and office- or center-based treatment of venous, vascular, hernia, pelvic, reconstructive, and related conditions. The organization appears to operate as a healthcare delivery business rather than a drug-development biotech or pharmaceutical company. Public descriptions emphasize treatment of venous disease, pelvic congestion syndrome, uterine fibroids, lipedema, lymphedema, and hernias, along with related diagnostic and procedural services. The group has been associated with specialty centers and ambulatory surgery capabilities in Manhattan and has been described as co-founded by David Greuner and Adam Tonis. For biotech landscape purposes, it is best classified as a commercial clinical services provider rather than a therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NYC Surgical Associates.